Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The effect of insulin withdrawal on intermediary metabolism in patients with diabetes secondary to chronic pancreatitis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Urinary growth hormone excretion in acromegaly: diagnostic value in mild disease activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Impaired pancreatic polypeptide response to a meal in type 1 diabetic patients: vagal neuropathy or islet cell dysfunction?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Effects of thyrotropin-releasing hormone on regional cerebral blood flow in man

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • S Larsen
  • J Hilsted
  • E K Philipsen
  • B Tronier
  • M Damkjaer Nielsen
  • H Worning
Vis graf over relationer
Insulin was withdrawn from 7 patients with Type I (insulin-dependent) diabetes and 4 patients with insulin-dependent diabetes secondary to chronic pancreatitis, both groups without residual beta-cell function. Median plasma glucagon concentrations rose slightly, but significantly after withdrawal of insulin in Type I diabetic patients (from 14 (range: 11-16) to 19 (14-25) pmol/l by 6 h), but not in the patients with secondary diabetes. This was accompanied by a significantly higher increase in blood glucose concentration from 5.1 (4.9-5.7) to 15.2 (12.9-18.1) mmol/l by 6 h in Type I diabetic patients compared with patients with secondary diabetes (from 4.9 (4.3-6.7) to 13.1 (10.9-13.5) mmol/l) (p less than 0.01). Beta-hydroxybutyrate increased to a similar extent in the two groups, whereas no significant increases were found in glycerol and lactate in any of the groups. Increased secretion of glucagon is not essential for the development of hyperglycemia and ketonemia in patients with diabetes secondary to chronic pancreatitis, but may augment the degree of hyperglycemia in Type I diabetic patients compared with patients having secondary diabetes.
OriginalsprogEngelsk
TidsskriftActa Endocrinologica (Copenh)
Vol/bind124
Udgave nummer5
Sider (fra-til)510-5
Antal sider6
ISSN0001-5598
StatusUdgivet - maj 1991
Eksternt udgivetJa

ID: 40201010